Post by Octapharma Canada
1,670 followers
๐ฆ๐๐ฎ๐ป๐ฑ๐ฎ๐ฟ๐ฑ๐ ๐ฎ๐ฟ๐ฒ ๐บ๐ผ๐๐ฒ๐ฑ ๐ฏ๐ ๐ฝ๐ฒ๐ผ๐ฝ๐น๐ฒ, ๐ฎ๐ป๐ฑ ๐ฏ๐ ๐๐ต๐ฒ ๐ฎ๐ฐ๐๐ถ๐ผ๐ป๐ ๐๐ต๐ฒ๐ ๐๐ฎ๐ธ๐ฒ. In VWD, the need is well understood. Bleeding risk shifts across life stages, procedures, and the in-between decisions that donโt make it into protocols. Yet, the standards meant to guide care remain largely static - built for moments, not for movement. Closing that gap happens when hard questions are asked and addressed:ย ย โข Why does variability in VWD care still persist?ย ย โข Why is evidence not consistently translating into practice?ย ย โข Why is VWD treated as isolated bleeding events, and not managed proactively like in Hemophilia? This week, the third Rethink VWD Symposium brings together healthcare professionals and advocates to work through these questions and define what equitable, proactive, and specific standards of care look like in VWD. ๐ฆ๐๐ฎ๐ป๐ฑ๐ฎ๐ฟ๐ฑ๐ ๐ฑ๐ผ๐ปโ๐ ๐ฟ๐ฎ๐ถ๐๐ฒ ๐๐ต๐ฒ๐บ๐๐ฒ๐น๐๐ฒ๐. People do. Comment below or send us a message if you want to know more. #Hematology #BleedingDisorders #vonWillebrandDisease #RethinkVWD
Video Content